Cited by 273Ovarian function and disordersAdipokines, Inflammation, and Metabolic DiseasesCardiovascular Disease and Adiposity

Omentin-1, a Novel Adipokine, Is Decreased in Overweight Insulin-Resistant Women With Polycystic Ovary Syndrome

Tan, Bee K., Adya, Raghu, Farhatullah, S., Lewandowski, Kris C., O’Hare, Paul, Lehnert, Hendrik, Randeva, Harpal S.·2008·Diabetes

Abstract

OBJECTIVE: Polycystic ovary syndrome (PCOS) is associated with insulin resistance and obesity. Recent studies have shown that plasma omentin-1 levels decrease with obesity. Currently, no data exist on the relative expression and regulation of omentin-1 in adipose tissue of women with PCOS. The objective of this study was to assess mRNA and protein levels of omentin-1, including circulating omentin-1, in omental adipose tissue of women with PCOS and matched control subjects. Ex vivo and in vivo regulation of adipose tissue omentin-1 was also studied. RESEARCH DESIGN AND METHODS: Real-time RT-PCR and Western blotting were used to assess mRNA and protein expression of omentin-1. Plasma omentin-1 was measured by enzyme-linked immunosorbent assay. The effects of d-glucose, insulin, and gonadal and adrenal steroids on adipose tissue omentin-1 were analyzed ex vivo. The in vivo effects of insulin (hyperinsulinemia) on omentin-1 levels were also assessed by a prolonged insulin-glucose infusion. RESULTS: In addition to decreased plasma omentin-1 levels in women with PCOS (P < 0.05), compared with control subjects, there was significantly lower levels of omentin-1 mRNA (P < 0.01) and protein (P < 0.05) in omental adipose tissue of women with PCOS (P < 0.01). Furthermore, in omental adipose tissue explants, insulin and glucose significantly dose-dependently decreased omentin-1 mRNA expression, protein levels, and secretion into conditioned media (P < 0.05, P < 0.01). Also, hyperinsulinemic induction in healthy subjects significantly reduced plasma omentin-1 levels (P < 0.01). CONCLUSIONS: Our novel findings reveal that omentin-1 is downregulated by insulin and glucose. These may, in part, explain the decreased omentin-1 levels observed in our overweight women with PCOS.

Integrity signals

Registry

Crossref · 10.2337/db07-0990

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • High leptin levels may lead to insulin resistance in nonobese PCOS patients by promoting four events: inhibition of phosphoenolpyruvate carboxykinase, fat deposition in skeletal muscle cells, fat breakdown and free fatty acid production, and direct inhibition of basal and glucose-stimulated insulin secretion.

    “High leptin levels may lead to IR in nonobese PCOS patients by promoting the following events: (i) inhibition of phosphoenolpyruvate carboxykinase, causing decreased hepatic glucose oxidation and increased hepatic glycogen reserve; (ii) fat deposition in skeletal muscle cells; (iii) fat breakdown and free fatty acid production; and (iv) direct inhibition of basal insulin secretion and glucose-stim”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tan, B. K., Adya, R., Farhatullah, S., Lewandowski, K. C., O’Hare, P., Lehnert, H., & Randeva, H. S.
Affiliations
  • University of Warwick (GB)
  • Endocrinology and Metabolism Group, Clinical Sciences Research Institute, Warwick Medical School, University of Warwick, Coventry, U.K
Venue
Diabetes
Published
2008-04-01
Volume
57
Issue
4
Pages
801-808
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2110727962
Cited by
273
References
20
Citations by year
2026: 4 · 2025: 10 · 2024: 11 · 2023: 16 · 2022: 15 · 2021: 18 · 2020: 17 · 2019: 19 · 2018: 16 · 2017: 14 · 2016: 17 · 2015: 21 · 2014: 28 · 2013: 22 · 2012: 11
FWCI
13.13
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
Keywords
omentin-1, adipokines, polycystic ovary syndrome, insulin resistance, obesity, omental adipose tissue, glucose, hyperinsulinemia, sex steroids, adrenal steroids, overweight women
MeSH terms
Adult, Blood Glucose, Female, Gene Expression Regulation, Glucose, Humans, Insulin, Insulin Resistance, Lipids, Obesity, Polycystic Ovary Syndrome, Reference Values, RNA, Messenger, Body Mass Index, Cytokines, DNA, Complementary, Patient Selection, Reverse Transcriptase Polymerase Chain Reaction, Lectins, Overweight, GPI-Linked Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review